# OnCo record cambridge-prognostic-group (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/cambridge-prognostic-group/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "cambridge-prognostic-group" ;
  schema:name "Cambridge Prognostic Group (CPG 1 to 5)"@en ;
  schema:alternateName "CPG"@en, "CPG 1"@en, "CPG 2"@en, "CPG 3"@en, "CPG 4"@en, "CPG 5"@en, "Cambridge Prognostic Groups"@en, "Cambridge prognostic group"@en, "five-tier risk stratification"@en, "NICE risk stratification prostate"@en ;
  schema:description "The five-band risk score the NHS uses for prostate cancer that has not spread. It combines the grade group, the PSA and the T stage into one number from 1 to 5, and NICE writes its treatment advice in those numbers rather than in low, intermediate and high risk."@en ;
  schema:url <https://onco.cc/terms/cambridge-prognostic-group/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Prostate_cancer_staging> ;
  schema:citation <https://www.nice.org.uk/guidance/ng131/chapter/Recommendations>, <https://www.rcpath.org/static/8cc88604-2c8d-4df4-a99542df41c102af/G084-dataset-for-histopathology-reports-for-prostatic-carcinoma.pdf>, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459> ;
  onco:related <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/psa/>, <https://onco.cc/terms/active-surveillance-term/>, <https://onco.cc/terms/staging-systems/>, <https://onco.cc/terms/tnm-staging/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:terms <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/psa/>, <https://onco.cc/terms/tnm-prostate-cancer/>, <https://onco.cc/terms/percentage-gleason-pattern-4/> .